| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.00075 | 1 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.00073 | 1 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0007 | 1 |